Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-30 Chen Hongming Chief Scientific Officer Exercise or conversion +31,000 $2.30 $71K 86,849
2020-03-30 Chen Hongming Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −31,000 75,236
2020-03-16 Bazemore Todd Chief Operating Officer Purchase +10,000 $5.75 $58K 10,000
2020-03-13 Grunberg Gregory Director Purchase +2,534,854 $7.89 $20.0M 2,534,854
2020-03-13 Shah Rajeev M. Director Purchase +6,337,135 $7.89 $50.0M 10,874,613
2020-03-13 RA CAPITAL MANAGEMENT, L.P. Director Purchase +6,337,135 $7.89 $50.0M 10,874,613
2020-03-11 Paull Robert Bradley Director Other acquisition +1,287 2,361
2020-01-02 Iwicki Mark T Chief Executive Officer Grant or award · Stock Option (right to buy) +365,000 365,000
2020-01-02 Bazemore Todd Chief Operating Officer Grant or award · Stock Option (right to buy) +120,000 120,000
2020-01-02 Brazzell Romulus K Chief Medical Officer Grant or award · Stock Option (right to buy) +120,000 120,000
2020-01-02 Chen Hongming Chief Scientific Officer Grant or award · Stock Option (right to buy) +120,000 120,000
2020-01-02 Reumuth Mary Chief Financial Officer Grant or award · Stock Option (right to buy) +120,000 120,000
2020-01-02 Trachtenberg Eric Grant or award · Stock Option (right to buy) +120,000 120,000
2019-10-12 Bazemore Todd Chief Operating Officer Grant or award · Stock Option (right to buy) +175,000 175,000
2019-10-12 Trachtenberg Eric Grant or award · Stock Option (right to buy) +100,000 100,000
2019-08-19 Rosen Howard B Director Exercise or conversion +2,880 $0.68 $2K 2,880
2019-08-19 Rosen Howard B Director Exercise or conversion +1,944 $0.47 $914 4,824
2019-08-19 Rosen Howard B Director Exercise or conversion · Stock Option (right to buy) −2,880 0
2019-08-19 Rosen Howard B Director Exercise or conversion · Stock Option (right to buy) −1,944 0
2019-06-05 Rosen Howard B Director Grant or award · Stock Option (right to buy) +21,000 21,000

Page 18 of 19 · 378 trades